The Indian Pharmacopoeia Commission (IPC) signed a Memorandum of Understanding with the Uttar Pradesh Promote Pharma Council (UPPPC) on July 14, 2026, during the YEIDA MedTech Investors Meet & Site Visit 2026 held at India Expo Mart, Greater Noida. This strategic partnership aims to strengthen the pharmaceutical and medical device ecosystem by promoting quality standards, regulatory excellence, innovation, and capacity building across the sector.
The collaboration will focus on strengthening quality standards and regulatory compliance in both pharmaceutical and medical device industries. It will promote awareness of the Indian Pharmacopoeia, pharmacovigilance, and materiovigilance through joint training programs, workshops, and stakeholder awareness initiatives. The partnership will foster research, innovation, and industry-academia collaborations while supporting MSMEs by providing digital tools for adverse event reporting.
A key objective is to enhance patient safety through quality assurance and post-market surveillance initiatives. The MoU reflects IPC's commitment to advancing high-quality healthcare standards and strengthening India's regulatory framework, while contributing to Uttar Pradesh's growth as a leading hub for pharmaceuticals, medical devices, and healthcare technologies. The partnership aims to build a stronger ecosystem that promotes quality, safety, innovation, and global competitiveness.